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Copper, an Abandoned Player 




Copper has two key properties that endow it as an excellent active ingredient to 
be used in the “wound healing battle”. First, copper plays a key role in angiogenesis, 
dermal fibroblasts proliferation, upregulation of collagen and elastin fibers produc-
tion by dermal fibroblasts, and it serves as a cofactor of Lysyl oxidase needed for 
efficient dermal extracellular matrix (ECM) protein cross-linking. Secondly, copper 
has potent wide-spectrum biocidal properties. Both gram-positive and gram-
negative bacteria, including antibiotic resistant bacteria and hard to kill bacterial 
spores, fungi and viruses, when exposed to high copper concentrations, are killed. 
Copper has been used as a biocide for centuries by many different civilizations. 
Impregnation of copper oxide microparticles in wound dressings allows continuous 
release of copper ions. This results not only in the protection of the wounds and 
wound dressings from pathogens, but more importantly, enhances wound healing. 
The article discusses the molecular mechanisms of enhanced wound healing by the 
copper oxide impregnated dressings, which include in situ upregulation of pro-
angiogenic factors and increased blood vessel formation. It also includes clinical 
cases showing clearance of infection, induction of granulation and epithelializa-
tion of necrotic wounds, reduction of post-operative swelling inflammation and 
reduction of scar formation, in wounds when they were treated with copper oxide 
impregnated dressings. We show the positive outcome at all wound healing stages 
of using the copper impregnated wound dressings, indicating the neglected critical 
role copper plays in wound healing.
Keywords: copper oxide, wound dressings, wound healing, angiogenesis, 
extracellular matrix, chronic wounds
1. Introduction
Wounds normally heal in finely balanced, efficient, and ordered sequence of 
repair events distinguished by four distinct, but overlapping, phases: Hemostasis, 
Inflammation, Proliferation and Remodeling [1, 2]. These coordinated cellular 
and molecular events involve numerous processes such as cell proliferation, 
migration and differentiation. All of these processes demand a continued and 
efficient supply of oxygen and nutrients, due to the increased cellular biosyn-
thetic activities. Following wounding, the altered microenvironment, such as 
the reduced oxygen supply, initiates the release of factors by epidermal cells, 
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fibroblasts, macrophages and vascular endothelial cells, all of which stimulate 
neo-vascularization. The secreted factors include vascular endothelial cell growth 
factor (VEGF), fibroblast growth factor (FGF) and transforming growth factor 
(TGF)-β. VEGF is believed to be the most prevalent, efficacious, and long-term 
signal that is known to stimulate angiogenesis in wounds. TGF-β, especially TGF-
β1, is also a key cytokine that regulates the production and secretion of elastin 
and collagen [3]. Fibroblasts, which attach to fibrin and integrin cables, produce 
and secrete collagen and elastin that become cross-linked, forming the dermal 
extracellular matrix (ECM). This allows the restoration of the structure and 
function to the injured tissue [4, 5].
1.1 Chronic wounds
Chronic wounds or “hard to heal wounds” are characterized by extensive loss of 
the integument, clear necrosis, or signs of circulation impairment either localized 
or more extensive, usually in the limbs, or in pressure areas, leading to extensive 
loss of substance. Chronic wounds seem to be detained in one or more of the phases 
of wound healing, and some chronic wounds may never heal or may take years to 
do so. These wounds have lost the fine balance needed for wound repair, leading to 
chronic non-healing ulcers, associated with morbidity and mortality due to tis-
sue inflammation and infection [6]. Chronic wounds are usually associated with 
systemic pathologies [7] that cause ischemia, a restriction in blood supply to tissues. 
Ischemia occurs in diabetic patients due to atherosclerosis as well as microangio-
pathic disease [8], in chronic venous ulcers due to chronic venous insufficiency [9], 
in patients with autoimmune disease or under immunosuppressive drug therapy 
due to vasculitis [10] and in pressure sores due to necrosis of the integument [11]. 
Chronic wounds cause patients severe emotional and physical stress and create a 
significant financial burden on patients and the whole healthcare system. Chronic 
wounds require special attention and wound care.
1.2 Involvement of systemic copper in wound healing
Copper is an essential mineral involved in many of the physiological processes 
in all body tissues [12, 13], including the skin and integumentary system [14]. 
Many of the finely balanced wound healing repair mechanisms are dependent on 
their interaction with copper (thoroughly reviewed in [6]). This includes, Platelet-
derived growth factor (PDGF), involved in the hemostasis phase of wound 
healing, [15, 16]; VEGF and angiogenin, key growth factors that stimulate angio-
genesis, an essential process during the Proliferation Phase [17–23]; secretion of 
collagens (types I, II, and V), HSP-47 and elastin fiber components (elastin, fibril-
lins) by dermal fibroblasts during the Proliferation and Remodeling Phases [16, 
24, 25]; activity of Lysyl oxidase (LOX) needed for efficient extracellular matrix 
(ECM) protein cross-linking between elastin and collagen [26]; stabilization of 
the skin ECM once formed [27, 28]; modulation of integrins by differentiated 
keratinocytes during the Remodeling phase [29], and Matrix metalloproteinases 
(MMPs, mainly MMP-1, MMP-2, MMP-8, MMP-9) and the serine proteases 
(human neutrophil elastase, HNE) are the major groups of proteases involved in 
the wound healing process. It is thus not surprising that copper chelation delays 
wound closure [30]. Copper is also a cofactor of superoxide dismutase, an anti-
oxidant enzyme found in the skin that inhibits cellular oxidative effects, such as 
membrane damage and lipid peroxidation and protects against free radicals [19]. 
Copper is also a cofactor of tyrosinase, a melanin biosynthesis essential enzyme, 
responsible for skin and hair pigmentation.
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1.3 Copper and wound infections
Infections of the wound may delay wound healing, cause wound deterioration 
and even cause failure of healing [31]. This may occur through several different 
mechanisms: consistent and high production of inflammatory mediators, metabolic 
wastes and toxins; tissue hypoxia; causing hemorrhagic and fragile granulation tis-
sue; reducing fibroblast number and total collagen production; and interfering with 
reepithelization [32, 33]; reducing the available nutrients and oxygen needed by 
the host cells and causing neutrophils to be in an activated state producing cytolytic 
enzymes and free oxygen radicals [34]. In chronic wounds bacteria may be covered 
by biofilm and be protected from the host defenses and develop antibiotic resistance 
[31]. Thus, reducing the microbial contamination of wounds increases the capacity 
of the wound to heal.
Copper is also a needed mineral for the normal function of microorganisms [35]. 
However, the microorganisms need to carefully control the intracellular copper 
levels. This is since copper under anaerobic condition is found in the highly reactive 
cuprous form (Cu1+), and as such it can readily react with the microbial proteins, 
causing disruption of the protein structures by forming thiolate bonds with iron–
sulphur clusters [36]. Thus, above an exposure to a certain concentration of copper, 
microorganisms cannot cope with the excess copper and are killed [37, 38]. Several 
mechanisms for the potent biocidal activity of copper have been proposed, which 
include alteration of proteins and inhibition of their biological assembly and activ-
ity; plasma membrane permeabilization; and membrane lipid peroxidation [37]. 
In contrast to the resistant microbes that have evolved to antibiotics in less than 
50 years of use, tolerant microbes to copper are extremely rare even though copper 
has been a part of the earth for millions of years. This lack of resistance to copper 
may be explained by the capacity of copper to damage in parallel many key factors 
in micro-organisms [37].
2. Cuprous oxide impregnated wound dressing
2.1 General description
Copper oxide impregnated wound dressings, hereafter called COD, have been 
cleared for treatment of acute and chronic wounds, including diabetic ulcers, 
pressure sores, and venous ulcers, by the USA FDA, EU and other regulatory bodies 
worldwide. The COD are soft, single use wound dressings composed of an absorbent 
highly absorbent needle punch layer and one or two external non-binding nonwoven 
orange polypropylene layers. All layers are impregnated with copper oxide mic-
roparticles. The orange external layer(s) is intended to be in contact with the wound 
bed. The wound dressings are provided with or without an adhesive contour, sterile, 
in a sterilization pouch (Figure 1). The non-adhesive wound dressings can be cut, 
trimmed or fold over according to the size and shape of the wound. The dressings 
can be used up to 7 days or until they are completely soaked with wound exudate.
2.2 Antimicrobial efficacy
The COD exert potent wide spectrum antimicrobial efficacy (>4 log reductions), 
including when the dressings are completely soaked with wound exudate surrogate 
for 7 days, as demonstrated by us and by independent laboratories using the AATCC 
Test Method 100. Furthermore, the potent antimicrobial efficacy is maintained 
even after 7 consecutive microbial inoculations for 7 consecutive days (Figure 2). 
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The antimicrobial efficacy was demonstrated against the following microorganisms: 
Escherichia coli, Enterococcus faecalis, Enterobacter aerogenes, Klebsiella pneumoniae, 
Staphylococcus epidermis, Methicillin-resistant Staphylococcus aureus (MRSA) and 
Candida albicans. When compared with commercially available silver wound dress-
ings, the antimicrobial efficacy was significantly higher than 9 out of the 12 silver 
dressings studied, and as good as 3 silver dressings (Figure 3, unpublished data).
2.3 Molecular mechanisms of enhanced wound healing
The capacity of copper to enhance faster closure of full-thickness wounds 
was demonstrated in several wound animal models, [30, 39, 40], including in 
diabetic mice [41].
The capacity of the COD to directly enhance repair of chronic wounds by sup-
plying in situ essential copper lacking due to poor systemic blood supply (such as in 
diabetic ulcers), was demonstrated in a murine diabetic model considered to be the 
Figure 1. 
Copper oxide impregnated wound dressings. The COD are composed of an absorbent layer and one or two 
external layers. The dressings are provided (a) with or (b) without an adhesive contour. The external layer (c, 
orange layer) is a non-adherent polypropylene layer placed in contact with the wound bed, which allows the 
passage of the wound exudates into the internal layer (c, beige layer) that absorbs the wound exudates. COD 
with two external layers (d) are more appropriate for application in wound cavities and deep wounds. All 
layers are impregnated with copper oxide microparticles (e, white dots) that endow them with potent biocidal 
properties.
Figure 2. 
Continuous antimicrobial efficacy of COD even after 7 consecutive bacterial inoculations. Duplicate COD 
were inoculated with ~1 x 105 Klebsiella pneumonae CFU for 6 consecutive days and incubated at 37 °C. On the 
seven days the CODs and a Control wound dressings without copper were inoculated with ~4x105 CFU. After 
additional 24 hours of incubation at 37 °C, the bacteria were recovered and their viability determined. While 
no bacteria survived on the CODs, 4x105 viable bacteria were recovered from the control dressings.
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most suitable in diabetic wound healing studies [42]. Wounding and subsequent 
treatments were performed under aseptic conditions, so that the possible effects of 
the copper dressings would not be related to their biocidal properties.
A phenotype similar to diabetes type 2 in mice is achieved via a homozygous 
point mutation on the leptin receptor gene (LEPR) in the hypothalamus. Genetically 
engineered diabetic mice (db/db) show significant wound-healing impairment com-
pared to wild-type mice [42]. Full-thickness single skin wounds were inflicted under 
sterile conditions on the dorsum of each animal followed by continuous dermal 
application of either COD or identical dressings without copper on the entire wound 
test site. Histological analysis of skin specimens taken from the diabetic mice treated 
with the COD 6, 12 and 17 days after wounding demonstrated a normal wound- 
healing process, including epidermal regeneration and granulation tissue formation, 
with numerous new blood vessels, chronic inflammatory infiltrate, generation of 
new hair follicles and sebaceous glands, and fibroplasia [41].
The very clear increase in angiogenesis in the copper treated mice was con-
firmed by immunohistochemistry staining using the Von Willebrand Factor that 
stains capillaries. Analysis of mRNA expression levels in the wound sites of 84 
genes using real-time PCR gene-array analysis together with immunohistochem-
istry staining revealed the upregulation of several angiogenic factors, such as 
Vascular endothelial growth factor (VEGF). Based on the analysis performed a 
molecular mechanism was suggested in which a redox between cuprous oxide and 
cupric oxide generates hypoxia that induces the upregulation of Hypoxia-inducible 
factor-1alpha (Hif-1α) in the dermal layer, apparently in macrophages [41]. The 
upregulation of Hif-1α then induces a chain of events, depicted in Figure 4, which 
lead to endothelial cell migration and proliferation, production of new blood 
capillaries (angiogenesis), immune cell recruitment, fibroblast migration, intense 
metabolism, increased secretion of extracellular matrix proteins, and increased 
epithelialization.
2.4  Clinical cases showing the enhancement of the COD at all stages of wound 
healing
The following cases illustrates the ability of COD to affect infection reduc-
tion, angiogenesis and granulation tissue formation, as well as epithelial tissue 
formation, in hard to heal wounds. In addition, we describe cases of reduction 
Figure 3. 
Antimicrobial efficacy comparison between the COD and commercially available silver dressings. The 
wound dressings were inoculated with ~106 (left panel) and 4x104 (right panel) MRSA CFU. After 1 hour of 
incubation at 37 °C the bacteria were recovered from the dressings and their viability was determined.
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of post-operative swelling and better post-surgery scar formation. All photos are 
published in the book with the patients’ consent.
2.4.1 Clearance of infection, induction of granulation and epithelialization
Fifty-seven years old male, with history of non-insulin-dependent diabetes melli-
tus (NIDDM), suffering from ulcers in both feet, mainly on the right side (Figure 5a). 
The etiology was mainly due to vasculitis type reaction (acute leukocytoclastic vasculi-
tis), with minor large arteries involvement (for which angiographic intervention with 
percutaneous opening of the superficial femoral artery was carried out). The patient 
was treated with high dose steroids, immunosuppressive medication (Azathioprine, 
Imuran) and broad-spectrum antibiotic treatment. The patient right foot worsened 
with development of necrosis mainly in the medial toes, with the infection spreading 
to involve the tendons and the plantar fascia. Deep ulcers were present over the medial 
aspect of the heel and the lateral aspects of the foot (Figures 5a and b).
The patient underwent surgery to debride the wound including 1st and 2nd ray 
amputation. Cultures taken at surgery yielded Pseudomonas aeruginosa resistant to 
quinolones and the patient was treated with Imipenem. Five days later the patient 
underwent trans-metatarsal amputation. The wound was partially closed to prevent 
a loose flap. Nevertheless, necrosis of the edges of the flap was seen few days follow-
ing surgery (Figure 5c). Bedside debridement was carried out. At that time, culture 
taken from the second surgery revealed that the pseudomonas has now developed 
resistance to carbapenems and it was decided to stop the antibiotic treatment. The 
medial heel wound had at least 30% necrotic tissue. The lateral anterior wound had 
80–90% necrosis (Figure 5c and d).
Trans-tibial amputation deemed to be the next step. WBC count was 18,000, 
which was an improvement from previous higher levels, and the CRP was 3.0 (nor-
mal <0.5). However, since the patient’s overall condition was stable, it was decided 
to continue only with local wound care with COD. The dressings were placed deep 
in the plantar-fascial part of the amputation wound, on the edges of it and on the 
ulcers (Figure 5d and e). The dressings were replaced twice a week. Prontosan® 
irrigation was recommended during dressing change. No supplemental antibiotic 
was given.
Figure 4. 
Molecular mechanisms of enhanced wound healing by COD. (based on the model published in ref. [41]).
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The foot condition improved gradually. The superficial semi-necrotic ulcer at the 
heel and lateral aspect of the foot showed gradual absorption of the necrotic tissue, 
granulation and epithelization (Figures 5f-i). The main amputation wound, with 
large area and volume and inner cavity of 6–7 cm, gradually filled with granulation 
tissue (Figure 5g). The granulation tissue seemed to affect the necrotic tissue with 
autolysis (self-debridement, Figure 5i). New epithelium gradually covered the 
Figure 5. 
Clearance of infection, induction of granulation and epithelialization of necrotic wounds. a. Ulcers colonized 
with Pseudomonas aeruginosa were present on both feet, mainly on the right foot. b. The ulcers were present 
over the medial aspects of the heel and the lateral aspect of the foot. c. Two weeks following trans metatarsal 
amputation necrotic tissue was present on the edges of the partially closed flap. d. The COD dressings started to 
be used (Day 0) by placing them deep in the plantar-fascial part of the amputation wound and e. by covering 
the medial and latera ulcers. f. One week later, a reduction in the necrotic tissue and beginning of granulation 
tissue was observed in all wounds. g and h. After 2 months of COD treatment there was clear epithelialization 
(white arrows) in the lateral and medial ulcers and granulation tissue formation (yellow arrows) in the lateral 
and medial ulcers and in the main bulk of the amputation wound that can be seen through the remaining 
thin necrotic tissue. Cultures from the necrotic tissue were negative for pseudomonas (the resistant original 
pathogen). i. The granulation tissue seemed to affect the necrotic tissue with autolysis (self-debridement). j 
and k. After 5 months of COD treatment, the medial and lateral wounds were closed. l. The main wound was 
partially closed and the rest of the wound was with pink to red granulation tissue.
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healing wounds (Figure 5g and h). Microbial culture, taken from the necrotic tissue 
three months after cessation of antibiotic administration, did not yield pseudomo-
nas, although normal non-pathogenic colonizing bacteria were identified.
After 5 months of COD treatment, the medial and lateral wounds were closed 
(Figure 5j and k). The main wound was partially closed and the rest of the wound 
was with pink to red granulation tissue (Figure 5l).
2.4.2 Increased epithelization
The powerful ability of COD to promote epithelization is illustrated in the follow-
ing case of a 71 years old man with NIDDM and diabetic neuropathy. The patient had 
osteomyelitis of the calcaneus, which necessitated extensive debridement of the heel 
and the infected calcaneus bone. The wound did not heal and the calcaneus broke 
through area of weakness due to the missing bone, thus creating a rocker deformity. 
Repeated surgery with debridement of the soft tissue, correction of the foot align-
ment and fixation with Steinman pins was carried out (Figure 6a and b, 1-week 
Figure 6. 
Epithelization of a rocker deformity related plantar deep wound. The patient had resection of infected 
calcaneal bone with correction and stabilization of ensuing rocker deformity with Steinman pins. COD 
was applied at surgery. a. one week following surgery the deep calcaneal wound is evident’ without signs of 
infection. b. X-ray showing the inserted Steinman pins. The missing plantar calcaneal bone and the deep soft 
tissue void underneath can be seen. c. Three weeks post-surgery, following the use of the COD, skin began 
crawling from the side surface into the depth of the wound. Further coverage of the wound granulation tissue 
with epidermal tissue is seen after 7 weeks (d), 8 weeks (e) and 3.5 months (f) of COD treatment, resulting in 
95% complete closure of the wound at 4.5 months (g). h and i. lateral foot and Axial calcaneal X-rays of the 
foot 4.5 months after surgery. Although large soft tissue void is prominent, it is filled with practically normal 
looking skin that crawled in. During all this period the foot was treated solely with COD.
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post-surgery). At surgery and thereafter the wound was dressed with COD, which 
was changed weekly. While relatively rapid granulation seemed to fill the depth and 
walls of the large cavity, normal looking skin began crawling from the side surface 
into the depth of the wound. Figure 6c, taken 3 weeks post-surgery demonstrated 
epithelization beginning at the superficial wall of the cavity (arrows). This phenom-
enon is further demonstrated in the photos taken at 7, 8 weeks (Figure 6d and e), 
3.5- and 4.5-months post-surgery (Figure 6f and g). The corresponding x-rays at 
4.5 months are shown in Figure 6h and i.
2.4.3 Reduction of post-operative swelling and inflammation
62-year-old man suffered from degenerative changes of the 1st metatarso-
phalangeal joint (Hallux Rigidus) and metatarsalgia. The forefoot deformities 
included hallux valgus Interphalangeus, subluxed lesser MTPJ’s, hammer 2nd 
toe and Bunionette deformity (Figure 7a). Surgery included cheilectomy of 
the first metatarsal head, Akin-Moberg osteotomy of the base of the proximal 
phalanx of the big toe, Weil osteotomies of the 2nd and 3rd metatarsals, Chevron 
osteotomy of the 5th metatarsal and PIPJ arthrodesis to correct the 2nd hammer 
toe (Figure 7b). The later was fixed with Kirschner wires (KW) and so was the 
5th metatarsal. The 2nd and 3rd metatarsals were fixed with a screw and the bog 
toe proximal phalanx osteotomy was secured with absorbable suture. The foot 
was dressed with COD immediately after surgery with first dressing change after 
3 weeks. At that time, surgical wounds were without any sign of infection or 
inflammation (Figure 7c). Despite having 4 metatarsal osteotomies and one toe 
arthrodesis in any of these sites, there was no swelling to the degree that normal 
skin wrinkles could be observed (Figures 7c-e). This is in contrast to the usual 
significant swelling that is observed for several months after foot osteotomies.
Figure 7. 
Reduction of swelling after forefoot surgeries and osteotomies. a. Forefoot deformities in a 62-year-old man. 
Hallux valgus, hammer second toe, subluxed 2nd and 3rd metatarsophalangeal joints and Bunionette 
deformity are observed. b. X-ray image taken 2 months after surgery demonstrates osteotomy of the base of the 
proximal phalanx of the big toe, Weil osteotomies of the 2nd and 3rd metatarsals, Chevron osteotomy of the 5th 
metatarsal and PIPJ arthrodesis of the 2nd hammer toe (arrows). c. Clinical photo of the foot at first dressing 
change three weeks after surgery (COD dressings were applied during surgery). Surgical wounds are without 
any sign of inflammation and lack of swelling and skin wrinkles can be seen. The tip of the KW’s fixing the 
2nd toe and the 5th metatarsal are seen and marked with red arrows (the second toe KW is wrapped with 
plaster to prevent accidental pullout) d. Oblique view of the same foot at the same visit after stitches removal 
demonstrates clearly the reduction of swelling. e. Clinical photos taken at 5 weeks post-surgery. Skin wrinkles 




Reduction of scar formation – Case Report 1. a. Bunion surgery that included Chevron type osteotomy of 
the 1st metatarsal and fixation with two KW’s. b. X-Ray of the foot following surgery. c. Surgical incision 
appearance at two weeks post-surgery. d. Surgical incision appearance at four weeks post-surgery. e. X-Ray 
of the foot at 7 weeks post-surgery. f. Clinical appearance of the foot at seven weeks post-surgery. g. Surgical 
incision appearance at seven weeks post-surgery. h. Enlargement of the surgical site at seven weeks post-surgery. 
Comparison between the scar appearance after 7 weeks (i) and 2 weeks (j) post-surgery shows that most of the 
scar has disappeared and was not detectable even at high magnification (h).
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2.4.4 Reduction of scar formation
Reduction of scar formation may be difficult to prove or demonstrate since 
the final surgical incision healing is a function of surgical technique as well as the 
patient own tendency to produce hypertrophic scar or even keloid. We have there-
fore elected to present the reduced scar formation in two cases of bunion surgery. 
Figures 8 and 9 with unexpected rapid healing in one patients and very good 
healing despite basic tendency to hypertrophic scar in another patient.
2.4.4.1 Case report 1
The first one is a 20-year-old healthy woman who had bunion surgery which 
included Chevron type osteotomy of the 1st metatarsal and fixation with KW 
(Figure 8a). The surgical incision and the KW’s are seen at two weeks post-
surgery (clinical photos and x-rays, (Figure 8a and b). The KW’s were removed 
at 4 weeks. By that time nice healing of the surgical incision seems to have taken 
place (Figure 8c and d). At 7-weeks post-surgery, the osteotomy has healed and 
Figure 9. 
Reduction of scar formation – Case Report 2. a. X-ray of both feet showing 1st and 2nd metatarsal osteotomy 
due to hallux valgus and metatarsalgia. b. Surgical incision appearance at 2 weeks post-surgery. c. X-ray 
and d. photographs of both feet one-year post-surgery showing successful foot positioning. e.   Surgical incision 
appearance of right foot one-year post-surgery. f. Surgical incision appearance of right foot one-year post-
surgery. g. Hypertrophic scar 25 years post-surgery due to elbow fracture.
Wound Healing
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clinical appearance is satisfactory (Figure 8e and f). The surgical scar is very 
delicate (Figure 8g). A comparison between the original incision and its appear-
ance after 7-weeks shows that ~80% of the incision scar is not observed even in 
high resolution and magnification photography (Figures 8h-j). This implies that 
either direct epithelization has occurred or remodeling of the scar took place. The 
superb cosmetic results at 7-weeks seems to be beyond a “successful case” and we 
attribute it to the beneficial effect of copper oxide on wound healing.
2.4.4.2 Case report 2
The second case is of a 49-years-old healthy woman who underwent bilateral 
hallux valgus surgery, which included distal first metatarsal osteotomy, fixed with 
KW’s and Weil ostetomies of the 2nd (+ 3rd) metatarsals (Figure 9a). The feet were 
dressed with COD. Two weeks post-surgery swelling was minimal and even skin 
wrinkles could be seen (Figure 9b). One year post surgery the foot position is very 
good (Figure 9c and d). The dorsal incision scarring is minimal (Figure 9d), the 
medial scar on both feet is hardly visible (Figure 9e and f). The patient said she has 
a tendency to create hypertrophic scars, for example a scar following open reduc-
tion and internal fixation of elbow fracture 25 year ago (Figure 9g).
3. Discussion
Copper is a natural mineral, which is an essential element of nutrition due to its role 
in many of the physiological processes in all body tissues [12, 13]. We have reviewed the 
beneficial effect of copper in wound healing based on abundant basic science research 
as well as our cumulative experience with the use of COD. Copper has been known 
for its antimicrobial properties including against all common wound pathogens and 
resistant bacteria. Similar properties are attributed to silver. Indeed, silver-containing 
wound dressings are widely used in wound treatment to reduce the risk of wound and 
wound-dressing contamination [43]. It is desirable, of course, to have a wound dressing 
that also promotes wound healing. Previous research has shown the beneficial effect of 
copper on skin and integumentary system [14] as well as on wound healing in diabetic 
mice [41]. The mechanism by which copper exerts its positive roll has been shown to be 
through up-regulating the level of Hif-1α, which is a key protein in tissue generation, 
especially in conditions of ischemia, like in hard to heal wounds. In this regard copper 
differs from silver, which exerts the opposite effect on wound healing, probably by 
downregulating Hif-1α [44]. Therefore, the usefulness of silver-based dressing in pro-
moting wound healing is questionable, among others due to cellular toxicity [45, 46].
However, since copper has potent biocidal properties [37], but in contrast to 
silver, is an indispensable trace element extremely well metabolized by the human 
body [12], we hypothesized that it could substitute silver in wound dressings. This 
would be justified for the goal of reducing bio-contamination. But, even more 
importantly, are the key roles copper plays in skin generation and angiogenesis. 
We further hypothesized that the inability of wounds to heal in individuals with 
compromised peripheral blood supply (e.g., with vascular diseases or diabetics), 
is partially due to low levels of copper in the wound site [47]. We suggested that by 
using a copper oxide-containing wound dressing we would slowly release in situ 
copper ions needed for angiogenesis, skin regeneration and wound healing.
Based on the above, we prepared wound dressings containing copper oxide 
(COD, Figure 1). The COD, which possess potent biocidal properties (Figures 
2 and 3), were found to be safe in animal studies, showing no skin irritation and 
no local damage to open wounds or systemic pathological alterations in a porcine 
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full-thickness wound model (unpublished data). Indeed, the risk of adverse reac-
tions due to dermal contact with copper is extremely low [48, 49]. Furthermore, 
wounds inflicted in diabetic (db/db) mice under sterile conditions and kept covered 
throughout the study with sterile wound dressings demonstrated a statistically sig-
nificant enhancement of wound closure when the dressings contained copper oxide 
[41]. Enhanced wound healing was nearly that anticipated from wild-type mice, 
where similar full-thickness dorsal skin wounds reach complete closure 7–10 days 
earlier than in db/db mice [50]. In contrast, commercially-used silver-containing 
wound dressings did not accelerate wound healing in this model [41]. Following 
the clearance of the COD to be used clinically, we have found, as described in some 
representative cases in the article, the significantly better results obtained with the 
COD than SOC dressings, including silver-based wound dressings.
The demonstrated cases (Figures 5-9) show the several effects of COD on dif-
ferent stages and aspects of wounds healing. The effects were reduction of colonized 
bacteria and superficial infection, as well as increased granulation and epithelization, 
as demonstrated in Figure 5. Figure 6 shows rapid epithelization of normal looking 
plantar skin into the cavity underneath the calcaneus. In addition to wound closure, 
we see in Figures 7-9 improved healing process on primary closed clean surgical inci-
sions, which expresses itself in improved scar formation and reduces swelling.
Due to the effect of COD on the various stages of wound healing, we now often 
use the COD continuously during the various phases of wound treatment. For 
example, we apply them on debrided wounds after partial foot amputation due to 
diabetic foot infection (instead of povidone-iodine or chlorine based dressings), 
and as healing progresses, we use them to assist in filling the wound with granu-
lation tissue (for example, instead of using Negative Pressure Wound Therapy 
(NPWT)). Once the wound has filled with new tissue, we use the COD to help 
epithelization until full wound closure is achieved.
Another advantage of COD is the few dressing changes it needs, usually once 
or twice weekly. This makes it convenient to the patient and savvy for the health 
care system. In the hospital, COD may replace chlorine-based dressings (e.g. Eusol 
or Daikin solutions), which needs changes 2–3 times daily, and thus reduce the 
workload on the nursing staff as well as diminishing the risk of spreading resistant 
bacteria and cross contamination in the Ward.
Additional studies are needed to further elucidate the exact mechanisms by 
which copper stimulates wound healing. It is clear, however, that copper directly or 
indirectly stimulates many factors, some of which are impaired in diabetics and are 
important for keratinocytes and fibroblasts proliferation, epithelization, collagen 
synthesis, extracellular matrix remodeling and angiogenesis. Indeed, by utilizing 
COD dressings on chronic wounds, which had failed to heal or healed slowly with 
other well-recognized wound care protocols, we found improved wound healing 
kinetics and wound closure in most patients.
4. Conclusions
As demonstrated by the murine diabetic model [41], the positive effect of the 
copper oxide-containing dressings is not related solely to its potent biocidal proper-
ties, but to the direct stimulation of wound repair. No adverse events were recorded 
with the use of the copper dressings and all patients showed positive response to 
its application. Thus, copper dressings appear to hold significant promise in the 
clinician’s ongoing struggle to heal both acute and chronic wounds. Additional 
randomized, controlled studies should be conducted to further validate the efficacy 
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